Lumos Diagnostics Holdings Ltd. (LDXHF) Ratios
Lumos Diagnostics Holdings Ltd. Ratios
LDXHF's free cash flow for Q4 2026 was $-2.11M. For the 2026 fiscal year, LDXHF's free cash flow was decreased by $-2.31M and operating cash flow was $192.10K. See a summary of the company’s cash flow.
| Ratios | Jun 26 | Jun 25 | Jun 24 | Jun 23 | Jun 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.52 | 0.74 | 0.76 | 0.73 | 1.05 |
| Quick Ratio | 1.40 | 0.68 | 0.69 | 0.60 | 0.85 |
| Cash Ratio | 1.19 | 0.22 | 0.51 | 0.37 | 0.62 |
| Solvency Ratio | -0.14 | -0.32 | -0.30 | -0.33 | -2.33 |
| Operating Cash Flow Ratio | 0.08 | -1.07 | 0.07 | -1.18 | -1.41 |
| Short-Term Operating Cash Flow Coverage | 0.98 | 0.00 | 0.00 | -7.16 | 4.81 |
| Net Current Asset Value | $ 1.92M | $ -8.19M | $ -10.17M | $ -9.96M | $ -5.61M |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.15 | 0.34 | 0.30 | 0.38 | 0.19 |
| Debt-to-Equity Ratio | 0.26 | 1.13 | 1.13 | 1.03 | 0.40 |
| Debt-to-Capital Ratio | 0.21 | 0.53 | 0.53 | 0.51 | 0.29 |
| Long-Term Debt-to-Capital Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Financial Leverage Ratio | 1.78 | 3.38 | 3.78 | 2.68 | 2.07 |
| Debt Service Coverage Ratio | -3.59 | -236.68 | -5.58 | -2.87 | 7.17 |
| Interest Coverage Ratio | -6.90 | -392.10 | -7.30 | -17.68 | -138.87 |
| Debt to Market Cap | 0.02 | 0.00 | 0.00 | 0.83 | -0.27 |
| Interest Debt Per Share | 0.01 | 0.01 | 0.02 | 0.04 | 0.05 |
| Net Debt to EBITDA | 0.80 | -1.06 | -0.29 | -1.37 | 0.03 |
| Profitability Margins | |||||
| Gross Profit Margin | -58.68% | 63.25% | 63.77% | 50.54% | 38.31% |
| EBIT Margin | -107.11% | -57.30% | -72.63% | -81.63% | -231.32% |
| EBITDA Margin | -87.81% | -37.87% | -48.84% | -46.79% | -220.70% |
| Operating Profit Margin | -107.11% | -62.74% | -63.98% | -62.28% | -205.38% |
| Pretax Profit Margin | -41.33% | -57.46% | -77.19% | -85.15% | -393.16% |
| Net Profit Margin | -37.54% | -57.46% | -77.19% | -85.15% | -393.16% |
| Continuous Operations Profit Margin | -37.54% | -57.46% | -77.19% | -85.15% | -393.16% |
| Net Income Per EBT | 90.83% | 100.00% | 100.00% | 100.00% | 100.00% |
| EBT Per EBIT | 38.58% | 91.60% | 120.64% | 136.73% | 191.43% |
| Return on Assets (ROA) | -12.42% | -34.51% | -32.01% | -35.29% | -123.78% |
| Return on Equity (ROE) | -22.15% | -116.66% | -120.86% | -94.45% | -255.66% |
| Return on Capital Employed (ROCE) | -52.08% | -64.83% | -50.10% | -38.05% | -99.07% |
| Return on Invested Capital (ROIC) | -45.56% | -59.67% | -46.95% | -34.02% | -111.99% |
| Return on Tangible Assets | -18.57% | -56.87% | -36.53% | -61.75% | -187.29% |
| Earnings Yield | -8.56% | -59.45% | -87.04% | -556.11% | -331.12% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.08 | 11.96 | 16.56 | 11.84 | 6.15 |
| Payables Turnover | 9.80 | 3.35 | 7.39 | 4.58 | 4.94 |
| Inventory Turnover | 13.04 | 8.82 | 5.14 | 4.90 | 2.84 |
| Fixed Asset Turnover | 1.81 | 2.03 | 1.47 | 1.23 | 1.06 |
| Asset Turnover | 0.33 | 0.60 | 0.41 | 0.41 | 0.31 |
| Working Capital Turnover Ratio | 5.94 | -4.70 | -4.22 | -13.19 | 0.92 |
| Cash Conversion Cycle | 50.83 | -37.18 | 43.58 | 25.65 | 114.01 |
| Days of Sales Outstanding | 60.08 | 30.51 | 22.04 | 30.84 | 59.32 |
| Days of Inventory Outstanding | 27.99 | 41.39 | 70.95 | 74.46 | 128.52 |
| Days of Payables Outstanding | 37.23 | 109.09 | 49.41 | 79.64 | 73.82 |
| Operating Cycle | 88.06 | 71.91 | 92.99 | 105.29 | 187.83 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.00 | -0.01 | 0.00 | -0.04 | -0.12 |
| Free Cash Flow Per Share | -0.00 | -0.01 | 0.00 | -0.04 | -0.15 |
| Dividend Paid and CapEx Coverage Ratio | 0.40 | -176.11 | 9.65 | -62.18 | -4.14 |
| Capital Expenditure Coverage Ratio | 0.40 | -176.11 | 9.65 | -62.18 | -4.14 |
| Operating Cash Flow Coverage Ratio | 0.17 | -1.34 | 0.12 | -0.98 | -2.51 |
| Operating Cash Flow to Sales Ratio | 0.08 | -0.75 | 0.08 | -0.91 | -1.55 |
| Free Cash Flow Yield | -2.64% | -77.69% | 8.59% | -607.06% | -162.15% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | -11.72 | -1.68 | -1.15 | -0.18 | -0.30 |
| Price-to-Sales (P/S) Ratio | 4.38 | 0.97 | 0.89 | 0.15 | 1.19 |
| Price-to-Book (P/B) Ratio | 2.59 | 1.96 | 1.39 | 0.17 | 0.77 |
| Price-to-Free Cash Flow (P/FCF) Ratio | -37.94 | -1.29 | 11.64 | -0.16 | -0.62 |
| Price-to-Operating Cash Flow Ratio | 57.02 | -1.29 | 10.43 | -0.17 | -0.77 |
| Price-to-Earnings Growth (PEG) Ratio | 0.28 | 0.04 | 0.02 | 0.00 | -0.00 |
| Enterprise Value Multiple | -4.19 | -3.61 | -2.11 | -1.70 | -0.51 |
| Enterprise Value | 49.61M | 17.11M | 11.45M | 8.38M | 13.02M |
| EV to EBITDA | -4.19 | -3.61 | -2.11 | -1.70 | -0.51 |
| EV to Sales | 3.68 | 1.37 | 1.03 | 0.80 | 1.12 |
| EV to Free Cash Flow | -31.85 | -1.82 | 13.50 | -0.86 | -0.58 |
| EV to Operating Cash Flow | 47.87 | -1.83 | 12.11 | -0.87 | -0.72 |
| Tangible Book Value Per Share | 0.01 | -0.00 | 0.01 | -0.01 | 0.04 |
| Shareholders’ Equity Per Share | 0.03 | 0.01 | 0.01 | 0.04 | 0.12 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.09 | 0.00 | 0.00 | 0.00 | 0.00 |
| Revenue Per Share | 0.02 | 0.02 | 0.02 | 0.04 | 0.08 |
| Net Income Per Share | -0.01 | -0.01 | -0.02 | -0.04 | -0.30 |
| Tax Burden | 0.91 | 1.00 | 1.00 | 1.00 | 1.00 |
| Interest Burden | 0.39 | 1.00 | 1.06 | 1.04 | 1.70 |
| Research & Development to Revenue | 0.03 | 0.01 | 0.01 | 0.02 | 0.11 |
| SG&A to Revenue | 0.45 | 1.00 | 0.94 | 0.96 | 1.45 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.04 | 0.00 | 0.02 |
| Income Quality | -0.20 | 0.84 | -0.11 | 1.07 | 0.39 |
Currency in USD
